Friede T - Search Results

1

Phase I dose-escalation oncology trials with sequential multiple schedules.

Günhan BK, Weber S, Seroutou A, Friede T. Günhan BK, et al. Among authors: friede t. BMC Med Res Methodol. 2021 Apr 14;21(1):69. doi: 10.1186/s12874-021-01218-9. BMC Med Res Methodol. 2021. PMID: 33853539 Free PMC article.

2

Designing a seamless phase II/III clinical trial using early outcomes for treatment selection: an application in multiple sclerosis.

Friede T, Parsons N, Stallard N, Todd S, Valdes Marquez E, Chataway J, Nicholas R. Friede T, et al. Stat Med. 2011 Jun 15;30(13):1528-40. doi: 10.1002/sim.4202. Epub 2011 Feb 22. Stat Med. 2011. PMID: 21341301

3

Spline-based procedures for dose-finding studies with active control.

Helms HJ, Benda N, Zinserling J, Kneib T, Friede T. Helms HJ, et al. Among authors: friede t. Stat Med. 2015 Jan 30;34(2):232-48. doi: 10.1002/sim.6320. Epub 2014 Oct 16. Stat Med. 2015. PMID: 25319931 Free PMC article.

4

Hartung-Knapp-Sidik-Jonkman approach and its modification for random-effects meta-analysis with few studies.

Röver C, Knapp G, Friede T. Röver C, et al. Among authors: friede t. BMC Med Res Methodol. 2015 Nov 14;15:99. doi: 10.1186/s12874-015-0091-1. BMC Med Res Methodol. 2015. PMID: 26573817 Free PMC article.

5

EFSPI/PSI working group on data sharing: accessing and working with pharmaceutical clinical trial patient level datasets - a primer for academic researchers.

Sudlow R, Branson J, Friede T, Morgan D, Whately-Smith C. Sudlow R, et al. Among authors: friede t. BMC Med Res Methodol. 2016 Jul 8;16 Suppl 1(Suppl 1):73. doi: 10.1186/s12874-016-0171-x. BMC Med Res Methodol. 2016. PMID: 27410386 Free PMC article.

6

Dose-finding methods for Phase I clinical trials using pharmacokinetics in small populations.

Ursino M, Zohar S, Lentz F, Alberti C, Friede T, Stallard N, Comets E. Ursino M, et al. Among authors: friede t. Biom J. 2017 Jul;59(4):804-825. doi: 10.1002/bimj.201600084. Epub 2017 Mar 21. Biom J. 2017. PMID: 28321893 Free PMC article.

7

Using phase II data for the analysis of phase III studies: An application in rare diseases.

Wandel S, Neuenschwander B, Röver C, Friede T. Wandel S, et al. Among authors: friede t. Clin Trials. 2017 Jun;14(3):277-285. doi: 10.1177/1740774517699409. Epub 2017 Apr 7. Clin Trials. 2017. PMID: 28387537 Free PMC article.

8

A design-by-treatment interaction model for network meta-analysis and meta-regression with integrated nested Laplace approximations.

Günhan BK, Friede T, Held L. Günhan BK, et al. Among authors: friede t. Res Synth Methods. 2018 Jun;9(2):179-194. doi: 10.1002/jrsm.1285. Epub 2018 Jan 16. Res Synth Methods. 2018. PMID: 29193801 Free PMC article.

9

dfpk: An R-package for Bayesian dose-finding designs using pharmacokinetics (PK) for phase I clinical trials.

Toumazi A, Comets E, Alberti C, Friede T, Lentz F, Stallard N, Zohar S, Ursino M. Toumazi A, et al. Among authors: friede t. Comput Methods Programs Biomed. 2018 Apr;157:163-177. doi: 10.1016/j.cmpb.2018.01.023. Epub 2018 Jan 31. Comput Methods Programs Biomed. 2018. PMID: 29477425 Free article.

10

Group sequential designs with robust semiparametric recurrent event models.

Mütze T, Glimm E, Schmidli H, Friede T. Mütze T, et al. Among authors: friede t. Stat Methods Med Res. 2019 Aug;28(8):2385-2403. doi: 10.1177/0962280218780538. Epub 2018 Jun 11. Stat Methods Med Res. 2019. PMID: 29890892

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

385 results

Search Page

Filters